Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Oct 31, 2025 | (Q4)Oct 31, 2025 | (Q3)Jul 31, 2025 | (Q2)Apr 30, 2025 | (Q1)Jan 31, 2025 | (FY)Oct 31, 2024 | (Q4)Oct 31, 2024 | (Q3)Jul 31, 2024 | (Q2)Apr 30, 2024 | (Q1)Jan 31, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 11.15%36.2M | 15.49%10.18M | -30.40%6.57M | 46.12%9.34M | 27.59%10.11M | 18.85%32.57M | 1.28%8.82M | 30.03%9.44M | 6.39M | 7.92M |
| Cost of revenue | 10.54%14.37M | 31.68%4.48M | -43.63%2.34M | 67.06%4.17M | 14.71%3.38M | 36.29%13M | -7.02%3.41M | 85.28%4.16M | 2.49M | 2.94M |
| Gross profit | 11.55%21.83M | 5.31%5.7M | -19.98%4.23M | 32.71%5.17M | 35.21%6.73M | 9.54%19.57M | 7.31%5.41M | 5.29%5.28M | 3.9M | 4.98M |
| Operating expense | 15.14%8.98M | -15.64%2.18M | 0.50%1.79M | 37.39%2.34M | 55.29%2.67M | -31.02%7.8M | -58.28%2.59M | 5.41%1.78M | 1.7M | 1.72M |
| Selling and administrative expenses | 15.14%8.98M | -15.64%2.18M | 0.50%1.79M | 37.39%2.34M | 55.29%2.67M | -30.50%7.8M | 14.12%2.59M | 5.41%1.78M | --1.7M | --1.72M |
| -General and administrative expense | 15.14%8.98M | -15.64%2.18M | 0.50%1.79M | 37.39%2.34M | 55.29%2.67M | -30.50%7.8M | 14.12%2.59M | 5.41%1.78M | --1.7M | --1.72M |
| Other operating expenses | ---- | ---- | ---- | ---- | ---- | 25.49%106K | ---- | ---- | ---- | ---- |
| Operating profit | 9.17%12.84M | 24.47%3.52M | -30.42%2.43M | 29.08%2.83M | 24.59%4.06M | 79.57%11.76M | 344.90%2.83M | 5.24%3.5M | 2.19M | 3.26M |
| Net non-operating interest income (expenses) | -14.19%3.73M | -10.75%992.25K | 5.94%1.05M | -27.68%834.87K | -21.68%853.99K | 45.34%4.34M | 15.08%1.11M | 37.46%987.91K | 1.15M | 1.09M |
| Non-operating interest income | -14.39%3.73M | -10.98%992.25K | 5.69%1.05M | -27.81%836.44K | -21.85%856.01K | 44.52%4.36M | 14.69%1.11M | 36.74%991.43K | --1.16M | --1.1M |
| Non-operating interest expense | -71.27%4.46K | --0 | -63.85%1.27K | -63.18%1.57K | -59.43%2.02K | -43.99%15.53K | -51.21%2.78K | -44.94%3.52K | --4.26K | --4.98K |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 136.50%1.72M | 525.61%554.11K | -64.49%85.85K | -37.66%251.06K | -66.27%71.56K | -45.24%726.45K | -133.21%-130.19K | -20.35%241.76K | 402.75K | 212.13K |
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | ||||||||||
| Other non-operating income (expenses) | -18.13%1.58M | -36.24%605.9K | 49.94%623.98K | 260.99%799.92K | 17.00%303.08K | 20.58%1.92M | 105.08%950.35K | -26.79%416.17K | 221.59K | 259.04K |
| Income before tax | 5.89%19.87M | 19.17%5.67M | -18.53%4.19M | 18.75%4.72M | 9.72%5.29M | 50.52%18.76M | 612.94%4.76M | 4.66%5.14M | 3.97M | 4.82M |
| Income tax | 10.90%5.25M | 44.63%1.81M | -18.22%1.01M | 20.42%1.15M | 6.15%1.28M | 16.11%4.73M | 14.77%1.25M | 4.20%1.24M | 955K | 1.21M |
| Net income | 4.20%14.62M | 10.09%3.86M | -18.63%3.18M | 18.23%3.57M | 10.90%4.01M | 67.24%14.03M | 931.96%3.51M | 4.81%3.91M | 3.02M | 3.61M |
| Net income continuous operations | 4.20%14.62M | 10.09%3.86M | -18.63%3.18M | 18.23%3.57M | 10.90%4.01M | 67.24%14.03M | 931.96%3.51M | 4.81%3.91M | --3.02M | --3.61M |
| Noncontrolling interests | 47.02%-6.22K | 86.11%-1.63K | 9.52K | -13.15K | -952 | -11.73K | -11.73K | 0 | 0 | 0 |
| Net income attributable to the company | 4.16%14.62M | 9.77%3.86M | -18.88%3.17M | 18.66%3.58M | 10.93%4.01M | 67.38%14.04M | 934.74%3.52M | 4.81%3.91M | 3.02M | 3.61M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 4.16%14.62M | 9.77%3.86M | -18.88%3.17M | 18.66%3.58M | 10.93%4.01M | 67.38%14.04M | 934.74%3.52M | 4.81%3.91M | 3.02M | 3.61M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 4.46%0.0164 | 10.26%0.0043 | -20.45%0.0035 | 17.65%0.004 | 12.50%0.0045 | 41.44%0.0157 | 750.00%0.0039 | 5.39%0.0044 | 0.0034 | 0.004 |
| Diluted earnings per share | 4.46%0.0164 | 10.26%0.0043 | -20.45%0.0035 | 17.65%0.004 | 12.50%0.0045 | 41.44%0.0157 | 750.00%0.0039 | 5.39%0.0044 | 0.0034 | 0.004 |
| Dividend per share | 0.00%0.005 | 0 | 0.005 | 0 | 0 | 0.005 | 0 | 0 | 0 | 0.005 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.